Get started
Author

Daniel Skoloda

Observed names: Dan Skoloda, Daniel J. Skoloda
ORCID: 0000-0002-4149-1593
Observed ORCID: 0000-0002-4149-1593
OpenAlex ID: A5071288491
Safety and Efficacy of Rivaroxaban and Apixaban in Patients with Increased Body Mass: a Systematic Review
2021 · Margaret M. Buck, Alexa M. Haddon, et al. · Clinical Drug Investigation · 10
A pragmatic review of varenicline prescribing practices
2023 · Daniel Skoloda, Caitlin Dowd-Green, et al. · Journal of the American Pharmacists Association · 6
PDF
Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients
2024 · Daniel Skoloda, Matthew Newman, et al. · JCO Oncology Practice · 4
PDF
Racial Disparities in the Management of Myeloma Bone Disease: A Retrospective Cohort Study
2026 · Ruxandra M. Irimia, Valentina Goularte, et al. · JCO Oncology Practice
PDF
Works count: 4
Citation count: 20
H-index: 3
I10-index: 1
Year
Topic
Type